Impact of acquired immunodeficiency in dermatomycosis. Cases and controls study

Abstract

Background: In the population of HIV-infected patients, superficial mycoses may have different clinical manifestations, evolution and etiology from those found in the non-HIV population. Objectives: To describe superficial lesions of fungal etiology in HIV-infected patients and compare them with a control group. Materials and methods: 79 patients (25 HIV positive and 54 controls) were evaluated. A card was prepared with data: age, sex, description and location of the lesion, evolution time and previous treatment. Samples of skin and lines of lesions with suspected fungal etiology were taken and a mycological study was performed. Results: A slightly significant difference was observed between HIV reactive patients with respect to the control group in the number of cases of foot Tinea unguium. The clinical presentation of intertrigo was more observed in the group of HIV positive patients. Conclusions: Superficial mycoses are more common infections in HIV reactive patients, with mixed clinical presentations and the difference in CD4 count between the HIV population in successful ARV treatment does not modify the clinical presentation of dermatophytosis.